Anixa Biosciences Inc (ANIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 10-2025 | 10-2024 | 10-2023 | 10-2022 | 10-2021 | |
| Sales | 0 | 0 | 210 | 0 | 512 |
| Gross Profit | N/A | N/A | 210 | N/A | 512 |
| Operating Expenses | 11,701 | 13,831 | 11,221 | 13,875 | 13,648 |
| Operating Income | -11,701 | -13,831 | -11,011 | -13,875 | -13,136 |
| Other Income | 673 | 1,133 | 1,081 | 104 | 8 |
| Pre-tax Income | -11,028 | -12,698 | -9,930 | -13,771 | -13,128 |
| Net Income Continuous | -11,028 | -12,698 | -9,930 | -13,771 | -13,128 |
| Minority Interests | -101 | -144 | -119 | -176 | -174 |
| Net Income | $-10,927 | $-12,554 | $-9,811 | $-13,595 | $-12,954 |
| EPS Basic Total Ops | -0.34 | -0.39 | -0.32 | -0.45 | -0.45 |
| EPS Basic Continuous Ops | -0.34 | -0.40 | -0.32 | -0.45 | -0.46 |
| EPS Diluted Total Ops | -0.34 | -0.39 | -0.32 | -0.45 | -0.45 |
| EPS Diluted Continuous Ops | -0.34 | -0.40 | -0.32 | -0.45 | -0.46 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.39 | -0.32 | -0.45 | -0.45 |
| EBITDA(a) | $-11,808 | $-13,794 | $-10,965 | $-13,833 | $-13,076 |